흰쥐에서 에피게로카테친의 장기투여가 베라파밀의 약물동태에 미치는 영향 = The Effect of Long-term Administration of Epigallocatechin on the Pharmacokinetics of Verapamil in Rats

참고문헌 (Reference)

1 "생물학적동등성시험 표준지침" 식품의약품안전청 142-146, 2003

2 "verapamil in thetreatment of paroxysmal supraventricular Tachycardias" 447-453, 1974

3 "Verapamil proteinbinding in patients and in normal subjects" 21-26, 1981

4 "Verapamil kinetics in normal subjects and patientswith coronary artery spasm" 644-652, 1981

5 "Verapamil disposition in liver disease andintensive-case patients" 27-34, 1981

6 "Theinfluence of cimetidine on the pharmacokinetics of theenantiomers of verapamil in the dog during multiple oraldosing" 18 : 117-123, 1995

7 "The treatment of hypertension with verapamil" 351-354, 1978

8 "The pharmacology of verapamil Pharmacokinetics in normal subjects after intravenous drugadministration" 25-38, 1981

9 "The metabolism of D verapamil in man" 145-148, 1979

10 "The 24-hour ambulatory blood pressureprofile with verapamil" 22-27, 1982

11 "Tea catechins and polyphenols:health effects, metabolism, and antioxidant functions" 43 : 89-143, 2003

12 "Specific pharmacology of calcium inmyocardium Annual Review of Pharmacology and Toxicology" 149-166, 1977

13 "Relationship to alpha1­acid glycoprotein and drug efficacy" 485-490, 1983

14 "Physiologic disposition of verapamil in man" 605-612, 1976

15 "O v e r l a p i n gsubstrate specificities and tissue distribution of cytochromep450 3A and P-glycoprotein: implications for drug deliveryand activity in cancer chemotherapy" 13 : 129-134, 1995

16 "LAGRAN program for area"

17 "Jejunal absorption and metabolism of R/S-verapamil inhumans" 15 : 856-862, 1998

18 "Involvement of multidrug resistance-associatedproteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites" 310 : 222-227, 2003

19 "Inhibitionby green tea catechins of metabolic activation of procar-cinogens by human cytochrome P450" 479 : 197-206, 2001

20 "Inhibition ofP-glycoprotein function by tea catechins in KB-C2 cells" 56 : 1001-1005, 2004

21 "Inhibition of themutldrug resistance P-glycoprotein activity by green teapolyphenols" 1542 : 149-159, 2002

22 "Influence of mesocaval shunt surgery onverapamil kinetics BritishJournal of Clinical Pharmacology" 527-529, 1980

23 "Effects of verapamil on PR intervals in relation toverapamil plasma levels following single i and oraladministration and during chronic treatment" 919-925, 1980

24 "Effectof grapefruit juice on the pharmacokinetics and pharma-codynamics of verapamil enantiomers in healthy volunteers" 56 : 693-698, 2000

25 "Effect ofgrapefruit juice and smoking on verapamil concentrationsteady state" 58 : 45-53, 2002

26 "Effect of cimetidine on verapamil disposition" 654-657, 1985

27 "Die Anwendung eines mit stabilen isotopenmarkierten Arzneimittels zur simultanen Bestimmung derrelativen biologischem Verfugbarkeit einer verapamil retard University of Bonn" 1985

28 "Comparative cardiovascular actions ofverapamil and its major metabolites in the anesthetized dog" 247-254, 1978

29 "Clinical pharmacology of slow channelblocking agents Progress in Cardiovascular Diseases 흰쥐에서 에피게로카테친의 장기투여가 베라파밀의 약물동태에 미치는 영향 111J" 83-102, 20071982

30 "Chemistry and Applications ofGreen Tea" CRC Press, New York 1322-, 1997

31 "Antimutagenic and anticarcinogenicactivity of tea polyphenols" 69-97,

32 "An investigation of the cause of accumulation ofverapamil during regular dosing in patients" 512-516, 1985

33 "-verapamil after intravenousadministration British Journal of Clinical Pharmacology" 453-458, 1984